Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Viracta Therapeutics
3207
Viracta Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Viracta is advancing medicines based on its viral gene activation therapy approach to benefit patients with viral-associated cancers & other serious diseases.
Suggest edits
Raised
$18.4M
Follow us
Also headquartered in San Diego
Qualcomm
Dan
Intuit
Edge
GoFundMe
Industry
Illumina
TuSimple
Satechi
Bandsintown
Companies in the same industry
Storm Therapeutics
Envisagenics, Inc.
Jnana
Prevail Therapeutics
Cryofocus Biotech
panCELLa
BGI Tech
Dragonfly Tx
Cardiff Oncology
Nine Square Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Add round
04 Apr
2017
$18,400,000
Venture capital (Series B)
Wicklow Capital
,
Latterell Venture Partners
,
Forward Ventures
,
+1
Viracta nabs $18.4M, Soon-Shiong as vice chair in Series B
FierceBiotech
